U.S. Professional Services Stock News

Monument Capital Management has fully exited its position in Grand Canyon Education, Inc. (NasdaqGS:LOPE). The complete divestment follows recent company updates that include higher litigation reserves tied to ongoing lawsuits. The move removes one institutional holder from the shareholder base and may influence how some investors view the stock. Grand Canyon Education provides education services, supporting university partners with technology, academic services, and operations. The company...

Community Trust Bancorp, Inc. recently reported fourth-quarter 2025 net income of US$27.28 million and full-year net income of US$98.06 million, alongside the Board’s January 27, 2026 declaration of a US$0.53 per-share quarterly cash dividend payable on April 1, 2026 to shareholders of record on March 15, 2026. The bank’s higher quarterly and annual net interest income and earnings per share, combined with expanded operations across Kentucky, West Virginia, and Tennessee, highlight its role...

In late January 2026, Equity LifeStyle Properties, Inc. reported full-year 2025 results showing higher sales of US$1,282.53 million, revenue of US$1,531.38 million, and net income of US$386.49 million, while also announcing its 22nd consecutive annual dividend increase to US$2.17 per share for 2026 and issuing earnings guidance for the year. The combination of rising normalized Funds From Operations, consistent dividend growth, and management’s 2026 outlook reinforced the REIT’s...

Taysha Gene Therapies (NasdaqGS:TSHA) has dosed the first patient in its pivotal REVEAL trial of TSHA-102 for Rett syndrome. The REVEAL study design has received FDA approval, supporting the structure of this key registrational trial. The company expects updated safety and efficacy data from the trial in the first half of 2026. Taysha Gene Therapies enters this next clinical phase with its share price at $4.66 and a 3 year return of 278.9%. The stock has also recorded a 1 year return of...

What stands out about Erasca’s recent trading performance? Erasca (ERAS) has drawn fresh attention after a sharp share price move, with the stock showing a 1 day return of 0.95% and a month return of 195.54%, alongside a past 3 months return of 359.31%. See our latest analysis for Erasca. That sharp move in Erasca’s share price to US$10.61 comes on top of strong short term momentum, with a 30 day share price return of 195.54% and a very large 1 year total shareholder return that is well above...

Ross Stores recently reported a strong quarter, with comparable store sales rising and new store openings contributing to growth, while management kept expenses tightly controlled and reduced expected tariff impacts. The retailer’s focus on branded merchandise and refreshed marketing appears to be reinforcing its competitive position, supporting positive analyst sentiment ahead of its upcoming earnings release. Against this backdrop of improved same-store performance, we’ll explore how these...

Independent Bank Corp. reported past fourth-quarter and full-year 2025 results, with net interest income rising to US$212.49 million for the quarter and US$708.83 million for the year, and quarterly net income increasing to US$75.34 million alongside higher charge-offs. The bank also completed a US$60.86 million share repurchase of 912,528 shares, signaling management’s confidence while full-year earnings per share were slightly lower than the prior year. With recent share gains, we’ll...

Brookdale Senior Living recently issued guidance for 2025, projecting revenue of about US$3.20 billion versus US$3.10 billion in 2024, alongside a wider net loss of approximately US$263 million due largely to non-cash impairment charges. At the same time, the company outlined ambitious 2026 targets for revenue per available room growth and adjusted EBITDA, signaling management’s confidence in extracting more earnings power from its existing senior housing footprint. Next, we’ll examine how...

Fulton Financial Corporation recently reported its fourth-quarter and full-year 2025 results, showing higher net interest income and net income versus the prior year, while also modestly increasing net loan charge-offs and completing a multi-year share repurchase program totaling 3,286,445 shares for US$59.72 million. Alongside these figures, management pointed to meaningful momentum in consumer demand deposit account openings and strong loan origination trends, underscoring how its...

Federated Hermes, Inc. recently reported fourth-quarter 2025 results with higher revenue and net income year over year, affirmed a US$0.34 quarterly dividend, completed share repurchases under two authorizations, and announced that senior portfolio manager Mark Weiss, CFA, will lead the Prime Liquidity Group when longtime executive Paige Wilhelm retires on July 1, 2026. This combination of solid operating updates and a planned leadership handover in a US$242.7 billion prime money market...

Why Soleno Therapeutics Is Back on Investors’ Radar Soleno Therapeutics (SLNO) is drawing fresh attention after describing 2025 as a transformational year, highlighting early traction for VYKAT XR, and flagging upcoming full financial results alongside a busy investor conference schedule. See our latest analysis for Soleno Therapeutics. The latest 9.75% 1 day share price gain to US$42.32 comes after management framed 2025 as transformational and highlighted early VYKAT XR traction. However,...

Autolus Therapeutics plc ( NASDAQ:AUTL ) shareholders won't be pleased to see that the share price has had a very rough...

In recent days, Vital Farms has attracted heightened investor attention as analysts highlight expected earnings growth and reference its track record of beating revenue and earnings estimates. Amid this increased focus, a bullish thesis emphasizing Vital Farms’ premium brand positioning and resilience to egg price volatility has become a key talking point for investors. We’ll now examine how growing optimism around Vital Farms’ earnings outlook influences its investment narrative and...

Blue Bird has proposed an amendment to its certificate of incorporation that would limit the liability of certain officers for breaches of fiduciary duty. The change would be implemented through corporate bylaw updates, subject to shareholder approval. The proposal focuses on reshaping how accountability and legal exposure for specific executives are defined within the company. For investors watching NasdaqGM:BLBD, this governance move sits alongside a share price of $51.06 and recent...

HCA Healthcare (NYSE:HCA) is rolling out AI-driven programs across its hospital network to improve clinical workflows, revenue cycle processes, and patient care. The company recently expanded its collaboration with GE Healthcare to develop an AI-enabled fetal heart rate monitoring tool for use in labor and delivery. Multiple HCA hospitals have received recent recognition for clinical excellence, including placements on national "Best Hospitals" lists. HCA Healthcare, one of the largest...

If you are wondering whether General Electric's share price still offers value after its run, this article walks through what the current numbers may be telling you. GE closed at US$308.71, with returns of 4.6% over the last 7 days, a 3.8% decline over the last 30 days, a 3.8% decline year to date, and gains of 52.1% over 1 year, around 4x over 3 years and more than 4x over 5 years. Recent coverage has focused on General Electric's progress as a focused industrial company and investor...

Owlet, Inc. ( NYSE:OWLT ) shareholders have seen the share price descend 25% over the month. But that doesn't change...

Unsurprisingly, Carnival Corporation & plc's ( NYSE:CCL ) stock price was strong on the back of its healthy earnings...

Everspin Technologies (MRAM) is drawing fresh attention after Avalanche Technology filed a patent infringement lawsuit and a related US International Trade Commission complaint focused on Everspin’s Spin-transfer Torque MRAM product line. See our latest analysis for Everspin Technologies. The lawsuit arrives at a time when Everspin’s share price has shown strong momentum, with a 30 day share price return of 31.61% and a year to date share price return of 31.61%, while the 1 year total...

Acadia Healthcare Company reappointed Debra K. Osteen as Chief Executive Officer and board director after the departure of Christopher H. Hunter. Activist investor Engine Capital is urging the company to consider a review of options, including a potential sale or aggressive share buybacks. The leadership change and investor pressure come as the company trades at a share price of $13.21 under the ticker NasdaqGS:ACHC. For investors watching NasdaqGS:ACHC, this leadership reset lands at a...

Event context and why Flowco is on the radar Flowco Holdings (FLOC) has been drawing attention after recent share price moves, with the stock last closing at $21.16 and posting a month and past 3 months return that stands out in its recent history. See our latest analysis for Flowco Holdings. Recent trading has been strong in the short term, with a 30 day share price return of 11.25% and a 90 day share price return of 31.51%, although the 1 year total shareholder return of 24.56% decline...

Tronox Holdings plc recently issued fourth-quarter 2025 guidance, projecting US$730 million in revenue, and announced the permanent closure of its 46,000-metric-ton-per-year TiO2 plant in Fuzhou, China due to weak domestic demand and rising sulfur costs. The company expects to incur US$60–80 million in restructuring and related charges but targets annual cost savings exceeding US$15 million while maintaining its ability to serve customers through its broader global manufacturing...

In January 2026, AXT, Inc. announced that its board had determined Leonard J. LeBlanc to be independent under Nasdaq rules and appointed him Chair of the Audit Committee, with former chair Jesse Chen remaining as a committee member. This governance shift comes as AXT’s role as a key Indium Phosphide wafer supplier to AI-driven data centers has drawn heightened investor attention. Against this backdrop, we’ll examine how Mr. LeBlanc’s move to independent Audit Committee Chair influences AXT’s...

If you are wondering whether Morgan Stanley's recent share price puts it at a premium or still leaves some value on the table, this article is for you. The stock most recently closed at US$185.10, with returns of 1.8% over 7 days, 1.8% over 30 days, 1.8% year to date, 38.6% over 1 year, 106.6% over 3 years and 192.6% over 5 years. Recent coverage of large U.S. financial institutions has focused on how capital markets activity, trading volumes and wealth management trends are influencing...